[1] |
黄晓梅, 贺云鹏, 许元文. 慢性阻塞性肺疾病-哮喘重叠综合征和COPD患者临床特征的差异性[J]. 实用医学杂志,2016,32(15):2491-2494.
|
[2] |
Pouwels SD, Hesse L, Faiz A, et al. Susceptibility for cigarette smoke-induced DAMP release and DAMP-induced inflammation in COPD[J]. Am J Physiol Lung Cell Mol Physiol,2016,311(5):L881-L892.
|
[3] |
张弘, 蔡柏蔷. 慢性阻塞性肺疾病急性加重临床研究进展[J]. 中国呼吸与危重监护杂志,2016,15(2):198-202.
|
[4] |
张金彪, 胡海涛, 刘玉欣, 等. 改良NAP活性检测在慢性阻塞性肺疾病急性加重期诊治中的应用价值[J]. 山东医药,2016,56(12):65-67.
|
[5] |
黄书明, 王永莉. COPD急性加重期与COPD合并社区获得性肺炎的对比分析[J].国际呼吸杂志,2017,37(21):1618-1622.
|
[6] |
Sheikh K, Coxson HO, Parraga G. This is what COPD looks like[J]. Respirology,2016,21(2):224-236.
|
[7] |
Corrao S, Brunori G, Lupo U, et al. Effectiveness and safety of concurrent beta-blockers and inhaled bronchodilators in COPD with cardiovascular comorbidities[J]. Eur Respir Rev,2017,26(145):11035-11042.
|
[8] |
Çolak A, Yılmaz C, Toprak B, et al. Procalcitonin and CRP as biomarkers in discrimination of community-acquired pneumonia and exacerbation of COPD[J]. J Med Biochem,2017,36(2):122-126.
|
[9] |
胡绘, 赵苏, 孔德勇, 等. 联合检测hs-CRP、PCT和BNP在COPD急性恶化期中的诊断价值[J]. 重庆医学,2015(35):5010-5012.
|
[10] |
Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease[J]. J Allergy Clin Immunol,2016,138(1):16-27.
|
[11] |
葛均波, 徐永健主编. 内科学.第8版[M]. 人民卫生出版社,2013.
|
[12] |
Negewo NA, Gibson PG, McDonald VM. COPD and its comorbidities: Impact, measurement and mechanisms[J]. Respirology,2015,20(8):1160-1171.
|
[13] |
高晶晶, 程意, 罗勇. COPD常见共患病及其流行病学特点和临床意义[J]. 国际呼吸杂志,2017,37(1):70-75.
|
[14] |
Tripple JW, McCracken JL, Calhoun WJ. Biologic therapy in chronic obstructive pulmonary disease[J]. Immunol Allergy Clin North Am,2017,37(2):345-355.
|
[15] |
刘慧. 慢性阻塞性肺疾病流行病学及危险因素的研究进展[D]. 南昌大学,2017.
|
[16] |
肖甜, 陈晓英, 王娜, 等. 中国大城市社区慢性阻塞性肺部疾病患者药物使用现状研究[J]. 中华流行病学杂志,2017,38(2):142-146.
|
[17] |
López-Campos JL, Tan W, Soriano JB. Global burden of COPD[J]. Respirology,2016,21(1):14-23.
|
[18] |
Hare KM, Smith-Vaughan HC, Chang AB, et al. Propensity of pneumococcal carriage serotypes to infect the lower airways of children with chronicendobronchial infections[J]. Vaccine,2017,35(5):747-756.
|
[19] |
刘欣艳, 拓西平. 细胞因子/炎症因子及其通路在COPD合并营养不良中的研究进展[J]. 临床和实验医学杂志,2017,16(14):1454-1457.
|
[20] |
Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease[J]. J Allergy Clin Immunol,2016,138(1):16-27.
|
[21] |
潘丽娟, 毛毅敏, 孙瑜霞, 等. 慢性阻塞性肺疾病患者肺部感染程度与肺功能的相关性分析[J]. 中华医院感染学杂志,2017,27(14):3161-3164.
|
[22] |
金敬顺. 影响急诊高龄肺部感染患者预后危险因素的Logstic回归分析[J]. 临床急诊杂志,2016,17(7):521-523.
|
[23] |
刘道喜, 刘慧, 王晓明, 等. 慢阻肺患者肺部感染对呼吸功能与细胞因子表达的影响研究[J]. 中华医院感染学杂志,2017,27(5):1019-1022.
|
[24] |
周敏, 余祖琳, 王美芳, 等. 慢性阻塞性肺疾病患者肺部感染的临床特征及病原菌分布[J]. 中华医院感染学杂志,2017, 27(14):3158-3160.
|
[25] |
钟国泽. 不同病原体致COPD患者急性加重期血清炎症标志物改变及对患者临床转归的影响[J]. 中国微生态学杂志,2018,30(4):456-460.
|